ASPG and leukemia: Correspondingly, in a syngeneic murine leukemia model, the efficacy of asparaginase, a key enzyme in leukemia treatment that hydrolyzes asparagine and glutamine, was impaired in the presence of adipose-rich TME, which provides aa to the ALL, thus promoting leukemia development.